(Q39592837)

13 September 2017

title

Differentiation-inducing activity of hydroxycamptothecin on cancer stem-like cells derived from hepatocellular carcinoma (English)

1 reference

13 September 2017

Yi Zhang

1

1 reference

13 September 2017

Wen-Jie Song

2

1 reference

13 September 2017

Fu-Qin Zhang

3

1 reference

13 September 2017

Wei-Hui Liu

4

1 reference

13 September 2017

Ke-Feng Dou

5

1 reference

13 September 2017

language of work or name

1 reference

12 February 2011

1 reference

Digestive Diseases and Sciences

13 September 2017

published in

1 reference

13 September 2017

volume

56

1 reference

13 September 2017

issue

8

1 reference

13 September 2017

page(s)

2473-2481

1 reference

Major achievements in hepatocellular carcinoma

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Cancer stem cells--old concepts, new insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Side population cells derived from adult human liver generate hepatocyte-like cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Cancer stem cells are enriched in the side population cells in a mouse model of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

21 January 2018

Differentiation therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Induction of acute lymphocytic leukemia differentiation by maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Differentiation therapy in acute myelogenous leukemia (non-APL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Differentiation-inducing therapy for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

In vivo treatment with CPT-11 leads to differentiation of neuroblastoma xenografts and topoisomerase I alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Identification and differentiation of hepatic stem cells during liver development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Differentiation induction of human promyelocytic leukemia cells by 10-hydioxycamptothecin, a DNA topoisomerase I inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Side population cells isolated from mesenchymal neoplasms have tumor initiating potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Normal stem cells and cancer stem cells: similar and different

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Apoptosis signaling in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Cancer stem cells: cell culture, markers, and targets for new therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-011-1601-6

Differential regulation of hepatocyte-enriched transcription factors explains changes in albumin and transthyretin gene expression among hepatoma cells.

21 January 2018

1 reference

12 December 2020

Differences between human and mouse alpha-fetoprotein expression during early development

1 reference

12 December 2020

Topoisomerase inhibitors potentiate the effect of retinoic acid on cell growth inhibition and induction of differentiation of leukemia HL-60 cells

1 reference

12 December 2020

Suppression of ABCG2 inhibits cancer cell proliferation

1 reference

12 December 2020

ABCG2: structure, function and role in drug response

1 reference

12 December 2020

Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha.

1 reference

12 December 2020

1 reference

12 December 2020

Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma Hep G2 cells

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases

1 reference

12 December 2020

Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases

1 reference

12 December 2020

Topoisomerase I protein expression in primary colorectal cancer and recurrences after 5-FU-based adjuvant chemotherapy

1 reference

12 December 2020

Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors

1 reference

12 December 2020

10.1007/S10620-011-1601-6

Identifiers

DOI

1 reference

release_yas45jc47vcojphl6x3bnvwjxq

13 September 2017

Fatcat ID

0 references

1 reference